Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID04551560

Stress and Congestive Heart Failure

Led by Yale University · Updated on 2026-01-27

112

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

Sponsors

Y

Yale University

Lead Sponsor

N

National Heart, Lung, and Blood Institute (NHLBI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating whether acute psychological stress can trigger worsening of congestive heart failure (CHF) symptoms in patients with CHF. This study aims to understand the impact of stress and negative emotions on pulmonary artery pressure (PAP) and how stress-induced changes relate to heart failure exacerbations. It also seeks to identify risk factors that influence how patients respond to stress, including physiological and psychosocial factors. Participants will undergo a laboratory mental stress test and a field protocol using ecological momentary assessment (EMA). The laboratory session includes periods of rest, relaxation, stress, and recovery while monitoring PAP and blood pressure. Blood samples are taken to measure CHF-related biomarkers. In the field protocol, participants will monitor their PAP daily over six months and complete smartphone-based stress and sleep quality questionnaires. For one month, they will also complete evening assessments. During the study, participants complete psychosocial questionnaires online or on paper. Researchers review clinical outcomes through medical records and the Cardiomems Merlin database. The main outcome measured is pulmonary artery pressure over six months, with medication changes also tracked. The study involves ongoing monitoring and assessment to understand stress effects on heart failure progression.

CONDITIONS

Brief Title

Stress and Congestive Heart Failure

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Heart failure patients over 18 who have or will be receiving a Cardiomems implanted pulmonary artery pressure monitor.
Not Eligible

You will not qualify if you...

  • Patients unable to perform ecological momentary assessment or laboratory assessments due to cognitive, visual, language, or other disabilities.
  • Patients with Class IV heart failure.
  • Patients with conditions other than heart failure affecting pulmonary artery pressures (e.g., dialysis).
  • Patients with physical conditions that interfere with study participation.
  • Patients non-compliant with their pulmonary artery pressure monitoring.
  • Patients with chronic opioid use.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Laboratory Mental Stress Protocol

Duration - 1 day

Participants complete a laboratory mental stress protocol including resting, stress, and recovery periods while pulmonary artery pressure and blood pressure are monitored and psychosocial assessments are completed.

1 visit (in-person)

Field Ecological Momentary Assessment (EMA)

Duration - 6 months

Participants complete daily morning pulmonary artery pressure assessments and stress/emotion questionnaires via a smartphone app for 6 months. For one month, additional evening assessments and questionnaires are completed.

Daily morning assessments and questionnaires for 6 months, plus daily evening assessments and questionnaires for 1 month

Follow-up

Duration - Up to 6 months

Clinical outcomes are monitored through medical record review and the Cardiomems Merlin database, alongside baseline psychosocial questionnaires.

No additional visits; data collected through records and questionnaires

Trial Site Locations

Total: 2 locations

1

St. Francis Hospital

Hartford, Connecticut, United States, 06105

Actively Recruiting

2

Yale University

New Haven, Connecticut, United States, 06511

Actively Recruiting

Loading map...

Research Team

R

Rachel Lampert, MD

M

Matthew Burg

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Similar Trials

Assessing Changes in Myocardial Tissue and Blood in Patients...

Congestive Heart Failure

Actively Recruiting

3 locations

Care Transitions App for Patients With Multiple Chronic Cond...

Heart Failure

Actively Recruiting

1 location

Circulating Markers for Ischemic Heart Disease

Myocardial Infarction

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here